Boston Partners Has $19.94 Million Stake in Pediatrix Medical Group, Inc. $MD

Boston Partners decreased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 28.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,419,618 shares of the company’s stock after selling 562,271 shares during the period. Boston Partners owned 1.63% of Pediatrix Medical Group worth $19,936,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Allianz Asset Management GmbH raised its holdings in shares of Pediatrix Medical Group by 159.1% during the second quarter. Allianz Asset Management GmbH now owns 61,412 shares of the company’s stock valued at $881,000 after purchasing an additional 37,712 shares during the period. Russell Investments Group Ltd. increased its position in Pediatrix Medical Group by 2.9% in the 1st quarter. Russell Investments Group Ltd. now owns 219,184 shares of the company’s stock valued at $3,176,000 after buying an additional 6,127 shares in the last quarter. Strs Ohio bought a new stake in Pediatrix Medical Group in the 1st quarter valued at about $690,000. Counterpoint Mutual Funds LLC acquired a new position in Pediatrix Medical Group during the 2nd quarter worth approximately $755,000. Finally, LPL Financial LLC boosted its holdings in Pediatrix Medical Group by 55.5% in the first quarter. LPL Financial LLC now owns 144,318 shares of the company’s stock worth $2,091,000 after acquiring an additional 51,490 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $22.61 on Friday. The stock has a 50 day moving average of $17.75 and a 200 day moving average of $15.40. The company has a market capitalization of $1.94 billion, a price-to-earnings ratio of 17.53 and a beta of 1.20. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $22.98. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.21. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business had revenue of $492.88 million for the quarter, compared to analysts’ expectations of $476.45 million. During the same quarter in the previous year, the firm earned $0.44 earnings per share. The business’s revenue was down 3.6% on a year-over-year basis. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $23.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Leerink Partners boosted their price target on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, October 8th. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday. Finally, Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 7th. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.80.

Insiders Place Their Bets

In related news, Director Laura A. Linynsky sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $21.65, for a total transaction of $216,500.00. Following the completion of the sale, the director owned 32,232 shares in the company, valued at approximately $697,822.80. This trade represents a 23.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.90% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.